NICE updates guidance and extends use of omalizumab in severe allergic asthma
Omalizumab (Xolair) has been accepted by NICE for broader use in the...
Jump to:
The latest innovation from GP magazine to make your life easier: a new medical supplies portal bringing you more than 60,000 essential products.
www.GPsupermarket.com
Following a review, NICE have overturned their previous negative decision for abatacept...
Omalizumab (Xolair) has been accepted by NICE for broader use in the...
Patients with idiopathic pulmonary fibrosis can now benefit from the novel treatment...
Elvanse (lisdexamfetamine) is a long-acting pro-drug stimulant indicated for the treatment of...
Almirall has launched Constella (linaclotide) for the symptomatic treatment of moderate to...
Pfizer has launched Vyndaqel (tafamidis) to delay peripheral neurologic impairment in patients...
Children aged 2 months and older can now receive the Japanese encephalitis...
Onglyza (saxagliptin) can now be used in combination with metformin and a...
The Department of Health has notified healthcare professionals of a supply issue...
Abilify is now indicated for the treatment of moderate to severe manic...
Impulse control disorders such as pathological gambling, compulsive shopping or eating, increased...
The MHRA has advised healthcare professionals to be vigilant when prescribing denosumab...
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
Supplied by the National
Travel Health Network
and Centre (NaTHNaC)